Pfizer, US ink $5.29B deal for possible COVID-19 treatment
By TOM MURPHY AP Health Writer NEW YORK --- The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regu…
By TOM MURPHY AP Health Writer NEW YORK --- The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regu…